Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

T2500100

Trimyristin

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

Glyceryl trimyristate, 1,2,3-Tritetradecanoylglycerol, Glycerol trimyristate, Trimyristin

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
[CH3(CH2)12COOCH2]2CHOCO(CH2)12CH3
CAS Number:
555-45-3
Molecular Weight:
723.16
Beilstein:
1718242
MDL number:
MFCD00036229
UNSPSC Code:
41116107
PubChem Substance ID:
329826710
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

trimyristin

manufacturer/tradename

EDQM

mp

56-57 °C (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

−20°C

SMILES string

CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC

InChI

1S/C45H86O6/c1-4-7-10-13-16-19-22-25-28-31-34-37-43(46)49-40-42(51-45(48)39-36-33-30-27-24-21-18-15-12-9-6-3)41-50-44(47)38-35-32-29-26-23-20-17-14-11-8-5-2/h42H,4-41H2,1-3H3

InChI key

DUXYWXYOBMKGIN-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Trimyristin EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Storage Class Code

11 - Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 2

1 of 2

Phosphomolybdic Acid Solution

Sigma-Aldrich

HT153

Phosphomolybdic Acid Solution

Tricaprylin European Pharmacopoeia (EP) Reference Standard

T1978000

Tricaprylin

Yi-Ping Fang et al.
International journal of nanomedicine, 7, 4995-5005 (2012-10-12)
The synthetic potential chemotherapeutic agent 3-Chloro-4-[(4-methoxyphenyl) amino]furo[2,3-b]quinoline (PK-L4) is an analog of amsacrine. The half-life of PK-L4 is longer than that of amsacrine; however, PK-L4 is difficult to dissolve in aqueous media, which is problematic for administration by intravenous injection.
Prabagar Balakrishnan et al.
Pharmaceutical research, 33(1), 206-216 (2015-09-05)
To evaluate the anti-tumor effect of ceramide or trimethylphytosphingosine-iodide (TMP-I) containing solid lipid nanoparticles (SLNs) prepared using trymyristin, phosphatidylcholine (PC), and Pluronic P85 (P85) for intravenous delivery of docetaxel. Docetaxel-loaded SLNs using ceramide or TMP-I at 3.22% (w/w) with a
Krishnan Ganesh Prasath et al.
Journal of proteomics, 208, 103503-103503 (2019-08-28)
Candida albicans, a dimorphic opportunistic fungus is known to form robust biofilm and commonly associated with superficial and life threatening systemic infections. The repertoire of C. albicans infection is comprehensive due to its biofilm mediated virulence and occurrence of resistance
Kunal Jain et al.
Drug delivery, 22(7), 940-954 (2014-02-12)
The objective of the study was to optimize artemether-loaded nanostructured lipid carriers (ARM-NLC) for intranasal delivery using central composite design. ARM-NLC was prepared by microemulsion method with optimized formulation having particle size of 123.4 nm and zeta potential of -34.4
Sabrina Knoke et al.
Pharmaceutics, 13(2) (2021-02-03)
Knowledge about the release behavior and drug retention properties of colloidal carriers is of essential importance for quality control as well as to predict in vivo performance. When conducting release studies from such systems, the release media should preferentially contain
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service